Vig­il Neu­ro­science

Vig­il Neu­ro­science

Developing drugs for neurodegenerative diseases.

HQ location
Cambridge, United States
Launch date
Employees
Market cap
$376m
Enterprise value
$321m
Share price
$8.05 VIGL
Authorizing premium user...